Scott GangloffVice President, Global Biopharmaceutical Development at IncyteSpeaker
Scott Gangloff is chemical engineer with almost 30 years of experience in Biopharmaceutical Development and Manufacturing. Scott spent most of his early years at Bristol Myers Squibb, with various responsibilities in Bioprocess Development and Manufacturing, contributing to many currently licensed Biologics programs. In 2011, Scott joined colleagues to create the start-up Oncobiologics, where he was responsible for Process and Product Development of the biosimilars portfolio. In 2017, Scott joined Incyte Corporation where he is currently serving as Vice President, Global Biopharmaceutical Development, responsible for CMC development and related supply chain activities for the large molecule pipeline. During his tenure at Incyte, Scott has been responsible for the submission of numerous INDs and BLAs.